A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients may benefit if doctors stop calling certain early-stage changes to the ...
A new paper in the Journal of the National Cancer Institute indicates that patients may benefit if doctors stop calling certain early-stage changes to the prostate “cancer” at all.
Around one in eight men will develop prostate cancer in their lifetime, and the disease kills two out of three people infected with it, according to the Centers for Disease Control and Prevention.